Aaron Donnell
Allergy & Immunology · Chicago, ILNPI 1154304848
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,819 of the $13,459 with a category attached, or 73.0%. 32 manufacturers reported payments, led by Alk-abello, Inc at 31.3% of the total. Reporting peaked in 2021 at $4,931 and has fallen 65.3% since, to $1,711 in 2025.
Across 493 payments — averaging $27.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alk-abello, Inc$4K
- AstraZeneca$2K
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$861
- Covis Pharma GmbH$688
- Sanofi$676
- plus $4K from 26 others
What the payments were for
- Speaking & faculty fees$3,57527%
- Food & beverage$9,81973%
- Education$640%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alk-abello, Inc | 44 | $4,212 |
| AstraZeneca | 75 | $1,566 |
| GSK | 63 | $1,112 |
| Regeneron Healthcare Solutions, Inc. | 39 | $861 |
| Covis Pharma GmbH | 32 | $688 |
| Sanofi | 31 | $676 |
| CSL Behring | 19 | $589 |
| Novartis | 27 | $427 |
| Biocryst US Sales Co., LLC | 17 | $363 |
| Optinose US, Inc. | 20 | $296 |
| ARS Pharmaceuticals Operations, Inc. | 12 | $295 |
| Kaleo, Inc. | 15 | $286 |
| Genentech USA, Inc. | 12 | $280 |
| Teva Pharmaceuticals USA, Inc. | 20 | $243 |
| Aimmune Therapeutics, Inc. | 3 | $208 |
| LEO Pharma Inc. | 10 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $170 |
| Amgen | 8 | $165 |
| Shire North American Group Inc | 6 | $129 |
| Pfizer | 6 | $126 |
| Phadia US Inc. | 7 | $123 |
| Seqirus USA Inc | 4 | $89 |
| Lilly USA, LLC | 3 | $82 |
| Sanofi-aventis U.S. LLC | 1 | $57 |
| Hikma Pharmaceuticals USA | 3 | $48 |
| Biocryst Pharmaceuticals, Inc. | 2 | $45 |
| Organon | 2 | $40 |
| USWM, LLC | 2 | $36 |
| Sanofi Pasteur Inc. | 1 | $24 |
| Circassia Inc. | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,459 in reported general payments places this provider in the 80th percentile of 161 allergy & immunology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AirsupraAlbuterol Sulfate/Budesonide | 12 | $5,541 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaAirsupra | $1,566 | $5,54112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 161 allergy & immunology providers in Illinois.
Other allergy & immunology in Chicago
- Anju PetersChicago$563K
- Giselle MosnaimChicago$331K
- Amanda SalihChicago$160K
- Juanita MoraChicago$147K
- Christina CiaccioChicago$73K
- Michael FoggsChicago$71K
- Melanie MakhijaChicago$56K
- Whitney StevensChicago$34K
- Andrea Pappalardo WlochowiczChicago$33K
- Krishan ChhibaChicago$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.